UTMD
Utah Medical Products Inc
74.50$
+0.9%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -1.4% | -8.1% | -8.3% | -3.8% | -8.5% | +6.0% | +2.5% | -1.4% | -7.8% | -3.6% | -2.2% | – | |
| – | -22.6% | -12.6% | +1.8% | +1.5% | -18.9% | +8.8% | +17.4% | -3.0% | -9.2% | -20.2% | +10.1% | – | |
| – | +23.6% | -4.7% | -15.1% | -8.1% | +0.9% | +4.0% | -8.7% | +0.1% | -6.5% | +11.6% | -10.2% | – | |
| – | +5.8% | +82.2% | -4.1% | -32.5% | -29.7% | +28.1% | -12.9% | +23.7% | +26.9% | -27.4% | +0.0% | – | |
| – | +230.0% | -89.8% | +112.0% | -63.3% | +670.8% | -83.9% | +147.4% | +24.8% | -7.6% | -36.3% | +17.5% | – | |
| – | +77.9% | -8.6% | -20.0% | -16.1% | +23.7% | -0.3% | -22.0% | +31.7% | -6.5% | +18.7% | -23.3% | – | |
| – | -0.6% | -1.5% | -11.5% | -2.8% | -12.4% | +7.6% | +1.4% | -18.3% | -6.5% | +5.0% | +3.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4.9% | -4.4% | -12.2% | -0.8% | -13.5% | +6.8% | -0.6% | -13.7% | -6.1% | +2.4% | +3.3% | – | |
| – | -13.6% | +15.2% | -10.0% | -18.7% | +15.6% | +14.7% | -3.7% | -13.9% | -20.2% | +6.8% | +3.8% | – | |
| – | +8.9% | -7.7% | -12.7% | +3.2% | -18.6% | +4.8% | +0.2% | -13.7% | -2.5% | +1.5% | +3.1% | – | |
| – | -14.3% | -5.6% | -7.8% | +0.3% | -19.0% | +5.1% | +9.4% | -11.0% | -5.2% | +0.1% | -25.1% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.